Online semaglutide care should begin with a licensed clinical evaluation, not a promise to ship medication. Telehealth can make a visit more convenient, but the same prescribing, safety, and pharmacy standards still apply.
Important safety information about branded medicines. Semaglutide is the active ingredient in Ozempic and Wegovy, registered trademarks of Novo Nordisk A/S. Tirzepatide is the active ingredient in Mounjaro and Zepbound, registered trademarks of Eli Lilly and Company. These branded prescription medicines carry a boxed warning about the risk of thyroid C-cell tumors. They are contraindicated in people with a personal or family history of medullary thyroid carcinoma and people with Multiple Endocrine Neoplasia syndrome type 2. Serious risks described in their labeling can include pancreatitis, gallbladder problems, acute kidney injury, severe gastrointestinal reactions, serious allergic reactions, low blood sugar with certain diabetes medicines, and diabetic retinopathy complications. Review the official Prescribing Information and Medication Guide for Ozempic, Wegovy, Mounjaro, and Zepbound.
This page is general information, not medical advice. Talk to a licensed clinician about your situation.
A telehealth visit is still medical care
The clinician must be licensed in the state where you are physically located for the appointment. A real evaluation requires enough information to decide whether a prescription is appropriate. That can include health history, current medicines and supplements, allergies, prior treatment, relevant conditions, and possible risks.
The clinician may need records or laboratory information depending on the situation. They should explain the plan and how to ask questions after the visit. Completing a questionnaire or paying a program fee does not guarantee eligibility or a prescription.
Avoid a site that advertises automatic approval, does not identify the clinical provider, or offers prescription medication without a valid prescription. Convenience is useful only when the clinical process remains intact.
Clarify the product before moving forward
The word semaglutide identifies an active ingredient, not one universal product. An online service should plainly state whether it is discussing an FDA-approved finished drug product or a compounded preparation. These categories must not be blended.
If compounded semaglutide is discussed, this disclosure applies:
Compounded medications are not FDA-approved. FDA does not review them for safety, effectiveness, or manufacturing quality.
Compounded semaglutide is not Ozempic, Wegovy, Mounjaro, or Zepbound. It is not a generic or interchangeable version of any approved drug.
Compounded semaglutide may be dispensed only pursuant to a valid prescription issued by a licensed clinician after a clinical evaluation, and only from a state-licensed pharmacy. FDA explains this category in its human drug compounding overview.
Ask the service to identify the exact product category and the dispensing pharmacy. Do not rely on wording that calls a compounded preparation an approved brand, a generic version, or a substitute with equivalent results.
Verify the dispensing pharmacy
The pharmacy is responsible for reviewing and dispensing a valid prescription. It must be licensed to serve patients in your state, even if it ships from another state. A legitimate online program should tell you which pharmacy would be involved and give you enough information to verify it.
FDA's BeSafeRx guidance says a safe online pharmacy should require a prescription, provide a physical address and phone number, offer access to a licensed pharmacist, and hold a state pharmacy license. Your state board of pharmacy can help confirm licensing.
Ask how the pharmacy handles delivery, damaged packages, storage questions, and pharmacist consultations. The label should clearly identify what was dispensed and provide directions tied to the prescription. Contact the pharmacy and clinician if anything is missing or unclear.
Expect follow-up after the first visit
Online care should include a way to report side effects, update the clinician about other medicines, and ask questions. Find out who provides follow-up, how quickly routine messages are answered, and where to seek urgent care.
The prescribing clinician should guide any changes. Do not start, stop, share, or adjust prescription medication based on general online information. Do not use a schedule written for another person.
Keep an updated list of prescriptions, over-the-counter products, and supplements. Share it with each clinician and pharmacist involved in your care. This is especially important when more than one service is involved.
Understand each separate charge
An online program may have a clinical service fee. A pharmacy has a medication charge. Laboratory services and shipping may create other charges. A clear estimate identifies who charges each amount, what it covers, and whether it repeats.
Body Good's prices are service fees for the program described during intake. They are not the price of medication and are not a quote for any individual. Eligibility is determined by a clinician. Medication cost is separate and is not included in a Body Good service fee. The dispensing pharmacy charges separately for medication. Laboratory services, when clinically appropriate, may also be separate.
Body Good may provide coverage support, which means assistance with benefits checks and plan-requested paperwork. Approval and payment are determined by the health plan, not by Body Good. No coverage result or out-of-pocket amount is assured.
Ask for a written breakdown before agreeing to a recurring service. It should identify the service period, included follow-up, pharmacy charge, supplies, shipping, and any cancellation terms. If the prescription or pharmacy changes, request a new estimate.
The role of this site
This website offers general information and a pricing overview. It takes no payment, collects no protected health information, and runs no intake form. Checkout and intake happen on the separate Body Good site.
The intake allows information to be submitted for review. It is not automatic approval. A licensed clinician decides whether any prescription or care plan is appropriate, and a state-licensed pharmacy may dispense only after receiving a valid prescription.
Frequently asked questions
Is every semaglutide product found online FDA-approved?
No. Ask whether the specific product is an FDA-approved finished drug or a compounded preparation. Compounded medications are not FDA-approved and must not be described as generic or interchangeable versions of approved drugs.
Does telehealth remove the need for a prescription?
No. A licensed clinician must complete a clinical evaluation and decide whether to issue a valid prescription. A state-licensed pharmacy must handle dispensing.
How can I request a Body Good evaluation?
Start Body Good's secure clinical intake. Intake does not guarantee eligibility, a prescription, coverage, pharmacy dispensing, or a specific outcome.
Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Body Good is not affiliated with, endorsed by, sponsored by, or authorized by Eli Lilly and Company or Novo Nordisk A/S. All trademarks are the property of their respective owners.